On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment TEPOXX (tecovirimat 200 mg capsules) for smallpox, mpox, cowpox, as well as ...
Mar. 11 -- TUESDAY, March 10 (HealthDay News) -- A third-generation tissue-cultured smallpox vaccine shows promise, Japanese researchers report. "The threat of smallpox bioterrorism has prompted ...
Fortunately, researchers were able to create a vaccine against this virus. The virus injected is a live virus, but it isn’t the variola virus known to cause smallpox. Instead, the vaccinia virus is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback